0001493152-23-006389.txt : 20230301 0001493152-23-006389.hdr.sgml : 20230301 20230301160517 ACCESSION NUMBER: 0001493152-23-006389 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230227 FILED AS OF DATE: 20230301 DATE AS OF CHANGE: 20230301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SNYDER DAVID S CENTRAL INDEX KEY: 0001398625 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41583 FILM NUMBER: 23693407 MAIL ADDRESS: STREET 1: ONE SCIENCE COURT CITY: MADISON STATE: WI ZIP: 53711 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coya Therapeutics, Inc. CENTRAL INDEX KEY: 0001835022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 BUSINESS PHONE: 650.739.3939 MAIL ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 4 1 ownership.xml X0306 4 2023-02-27 0 0001835022 Coya Therapeutics, Inc. COYA 0001398625 SNYDER DAVID S 5850 SAN FELIPE ST., SUITE 500 HOUSTON, TX 77057 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 3.85 2023-02-27 4 A 0 115000 0 A 2033-02-27 Common Stock 115000 115000 D Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023. /s/ David Snyder 2023-03-01